Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens. [electronic resource]
Producer: 20080612Description: 651-9 p. digitalISSN:- 1527-6473
- Adult
- Aged
- Antimetabolites -- therapeutic use
- Calcineurin Inhibitors
- Case-Control Studies
- Creatinine -- blood
- Cyclosporine -- administration & dosage
- Disease Progression
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Female
- Graft Rejection -- etiology
- Humans
- Immunosuppressive Agents -- administration & dosage
- Liver Diseases -- drug therapy
- Liver Transplantation -- adverse effects
- Male
- Middle Aged
- Renal Insufficiency, Chronic -- chemically induced
- Renal Replacement Therapy
- Retrospective Studies
- Sirolimus -- administration & dosage
- Tacrolimus -- administration & dosage
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.